GENE ONLINE|News &
Opinion
Blog

Fezolinetant
FDA Approves Astellas’ Non-hormonal Menopause Treatment After Extended Review
2023-05-19
EMA Begins Regulatory Review For Astellas’ Fezolinetant
2022-10-03
Astellas’ Non-Hormonal Drug for Hot Flashes Shows Promise in Two Phase 3 Trials
2021-02-24
LATEST
An Interview with the Inventor of HPV Vaccine, Ian Frazer, Building a Firewall for Public Health
2024-02-29
Taiwan’s Drug Price Adjustments: Balancing Cost and Availability
2024-02-28
Neomorph Links Together With Novo Nordisk in a $1.46 Billion Molecular Glue Partnership Deal
2024-02-27
Breakthrough Study Shows Anti-IgE Antibody Safeguards Children with Multiple Food Allergies
2024-02-27
Cortisol: New Discoveries on its Impact Across Health, Culture, and Evolution
2024-02-26
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
EVENT
Scroll to Top